Roth, G.S.; Benhamou, M.; Teyssier, Y.; Seigneurin, A.; Abousalihac, M.; Sengel, C.; Seror, O.; Ghelfi, J.; Ganne-Carrié, N.; Blaise, L.;
et al. Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers 2021, 13, 812.
https://doi.org/10.3390/cancers13040812
AMA Style
Roth GS, Benhamou M, Teyssier Y, Seigneurin A, Abousalihac M, Sengel C, Seror O, Ghelfi J, Ganne-Carrié N, Blaise L,
et al. Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers. 2021; 13(4):812.
https://doi.org/10.3390/cancers13040812
Chicago/Turabian Style
Roth, Gaël S., Maxime Benhamou, Yann Teyssier, Arnaud Seigneurin, Mélodie Abousalihac, Christian Sengel, Olivier Seror, Julien Ghelfi, Nathalie Ganne-Carrié, Lorraine Blaise,
and et al. 2021. "Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis" Cancers 13, no. 4: 812.
https://doi.org/10.3390/cancers13040812
APA Style
Roth, G. S., Benhamou, M., Teyssier, Y., Seigneurin, A., Abousalihac, M., Sengel, C., Seror, O., Ghelfi, J., Ganne-Carrié, N., Blaise, L., Sutter, O., Decaens, T., & Nault, J. -C.
(2021). Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers, 13(4), 812.
https://doi.org/10.3390/cancers13040812
